Compare PACB & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PACB | CLPT |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 459.0M | 494.6M |
| IPO Year | 2010 | 2009 |
| Metric | PACB | CLPT |
|---|---|---|
| Price | $1.34 | $10.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $2.10 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 5.8M | 930.3K |
| Earning Date | 01-01-0001 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.22 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | $31,390,000.00 |
| Revenue This Year | $11.22 | $18.93 |
| Revenue Next Year | $12.41 | $51.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 3.04 | ★ 31.04 |
| 52 Week Low | $0.85 | $8.63 |
| 52 Week High | $2.73 | $30.10 |
| Indicator | PACB | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 34.34 | 42.10 |
| Support Level | $1.18 | $10.57 |
| Resistance Level | $1.37 | $11.69 |
| Average True Range (ATR) | 0.10 | 1.01 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 15.45 | 33.41 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.